EGFR overexpression has been previously reported in ovarian cancer [45], breast cancer [46], and hepatocellular carcinoma [47], and its expression negatively correlates with prognosis and survival rate in these patients. The gene discussed is EGFR; the disease is hepatocellular carcinoma.